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Objectives
After completion of this program, the reader should be able to:
1. Discuss the background and origin of the Zika virus,
including where the Zika virus has become endemic
in the United States.
2. Identify risk factors for contracting the Zika virus and
its common routes of transmission.
3. Recognize the signs and symptoms of the Zika virus.
4. Prepare an appropriate plan to manage patients presenting with Zika virus, including diagnostic testing,
treatment and counseling points.
5. Explain the logic behind the current investigational
vaccines targeted against the Zika virus.
Abstract
The Zika virus has become a growing concern as a global
pandemic. Since being identified in Uganda in 1947, the virus
has spread around the world, recently emerging in South
America with a great impact on Brazil. As of 2016, Zika has
made its appearance in the United States and is now actively
being transmitted in Florida. The virus is a mosquitovectored flavivirus primarily transmitted by the Aedes mosquito which infects a human through biting. Transmission
through sexual intercourse is also possible as well as transmission from a pregnant woman to her fetus. This latter form
of transmission presents the primary problem with the Zika
virus; transmission to the fetus can cause microcephaly as
well as other brain and developmental problems. Proper precautions should be taken based on these identified modes of
transmission. Symptoms of Zika are similar to flu-like symptoms, such as low-grade fever, muscle pain and headache.
About 20 percent of patients that come in contact with the
Zika virus will originally present as asymptomatic and will
not display symptoms until almost two weeks after initial
contact with the virus. Zika virus can remain in the blood for
about a week, but can remain in the semen for months. There
are a number of methods used to detect the Zika virusurine, blood or semen samples may be used to assess if a patient is infected.
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Introduction
The Zika virus was originally identified in Uganda in 194 7. It
has since spread around the world as two main strains, Asian
and African, distinguishable by detailed analysis of the ribonucleic acid (RNA) sequence. 1 This difference in sequence
relates to a variation in availability for potential glycosylation sites in the virus. The Asian strain is responsible for the
outbreaks seen in Brazil and the United States, after travelling through Pacific Island countries such as Malaysia (1969),
Philippines (2012) and Easter Island (2014). In late 2014
and early 2015, reports to the Brazilian Ministry of Health of
an "acute exanthematic disease" began following the 2014
Federation Internationale de Football Association (FIFA)
World Cup, and, in March 2015, the Zika virus was isolated in
patients in various regions of BraziJ.2 By May, the Brazilian
Ministry of Health recognized local transmission of the Zika
virus. In September, reports of microcephaly began to surface, and on Oct. 23, 2015, the Brazilian Ministry of Health
reported the occurrences to the World Health Organization.
As the link between Zika virus and microcephaly became
more apparent, the Brazilian Ministry of Health published
guidelines for the management of microcephaly. There were
an estimated 440,000 to 1,300,000 cases of Zika in Brazil in
2015 alone, and 508 cases of microcephaly were confirmed
by February 2016.
As of 2016, reports of Zika virus spread to the United States,
significantly increasing awareness of the disease. On Jan. 15,
2016, the Centers for Disease Control and Prevention (CDC)
released a health alert warning travelers and health care providers to be vigilant for the signs and symptoms of the Zika
virus as travel-associated cases had already been reported in
travelers returning to the United States.3 Since then, there
has been a rise in cases in the United States, most notably in
California, Florida, New York and Texas, with 4,389 travelassociated cases reported as of Dec. 7, 2016.4 As of the same
date, 185 locally acquired cases have been reported in the
United States: 184 in Florida and one in Texas. The first reports of local transmission came in late July from Miami,
Florida, where Zika virus was isolated in four patients, which
was likely caused by local Aedes aegypti mosquito bites, as
the patients had not recently traveled outside of the United
States. 5 Territories of the United States have also reported
locally acquired cases: 32,848 cases in Puerto Rico, 57 cases
in American Samoa and 807 cases in the Virgin Islands.
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Health care professionals and researchers have worked to
gather as much information about the disease as possible, in
order to inform the public about proper precautions.6 In
addition, possible treatments and vaccines are currently in
development. New information about the Zika virus is constantly being discovered, and the imperative task of keeping
the public informed has become an emerging role of health
care professionals.

problems for the child. These could include microcephaly,
decreased brain tissue, restricted joints, increased muscle
tone or damage to the eyes. The Zika virus has been identified in breast milk; however, to date, there have not been any
infections associated with breastfeeding. The proven benefits
of breast milk currently outweigh the potential risk of Zika
virus. Therefore, the CDC is still recommending breastfeeding in areas where the virus is prevalent.

Etiology and Transmission
The Zika virus is a mosquito-vectored flavivirus which uses
several mechanisms to alter host cellular pathways to favor
viral replication.7 Transmission of the Zika virus can occur
through several mechanisms: receiving a bite from an infected mosquito, vertical transmission from mother to child and
transmission through sexual activity.6 Less commonly, the
Zika virus may be transmitted via blood transfusion or
through laboratory exposure, though these are typically not a
concern in the general population. There have not been any
confirmed cases of transmission via blood transfusion in the
United States, though there have been cases reported in Brazil. Additionally, the virus has been identified in blood donors
in French Polynesia during several outbreaks. In one case
study, spread of the virus through sweat and tears was also
identified as a possible route oftransmission.s

An individual may also transmit the Zika virus to any sexual
partners.6 Sexual transmission can occur before, during or
after the infected individual develops symptoms. It has also
been hypothesized that an asymptomatic carrier can still
transmit the Zika virus to a sexual partner. The Zika virus has
been identified in the semen for up to six months after the
dissipation of symptoms, much longer than in the blood,
urine and vaginal fluids. For this reason, the CDC is currently
recommending the use of condoms for at least six months
after a man has returned from an area where Zika virus is
endemic or six months after he has received a positive diagnosis of Zika.

Transmission through the bite of a mosquito is the primary
mode of transmission associated with the Zika virus. 6 Mosquitos of the Aedes genus may be infected with the virus,
specifically the Aedes aegypti and Aedes albopictus species.
These species of mosquito are primary reservoirs for the
virus and can transmit other tropical diseases such as dengue fever and chikungunya. An infected mosquito can transmit the virus to a human through a bite. Likewise, a mosquito
may also become infected after biting a human infected with
the Zika virus. In turn, the newly infected mosquito may
spread the virus to any other human it bites. These mosquitos are aggressive daytime biters, though biting, and therefore transmission, is also possible at night.
Studies have been conducted that demonstrate vertical
transmission as a possible mechanism of survival of the Zika
virus in the Aedes aegypti mosquito.9 This is important when
considering environments that act as potential breeding
grounds for mosquitos. For instance, the Aedes mosquito
often lays eggs in standing water. 6 This potential form of vertical transmission within the viral reservoir may attribute to
disease survival. Vertical transmission in this manner is
certainly possible in tropical climates which the mosquitos
currently inhabit and may also be a concern in adverse conditions such as colder climates. 9 The mosquitos may lay eggs
that will hatch once the environment becomes favorable.9,10
The Aedes mosquitos typically exist in tropical climates, but
their range has extended to include the southern United
States, possibly allowing for local transmission in this area.6
If a pregnant female becomes infected, she can pass the Zika
virus to her fetus.6 Transmission may occur in utero or near
the time of birth and may result in a wide range of health
Winter 2017 Volume 8, Issue 1

Signs, Symptoms and Diagnosis
The Zika virus can manifest itself in many ways once it infects a host. A majority of those infected are asymptomatic or
display mild symptoms such as low-grade fever, joint pain,
maculopapular rash, arthralgia, nonpurulent conjunctivitis,
headaches and myalgia.11,12 Approximately one in five patients initially asymptomatic will develop symptoms as late
as 12 days after infection. In the asymptomatic population
without detectable symptoms, the Zika virus can still be
transmitted via blood primarily through blood transfusion
and sexual intercourse. 13 Typically, the Zika virus remains in
the blood of an infected individual for about a week, but can
remain in other fluids, such as semen, for much longer. If an
individual suspects that he or she is infected with the Zika
virus by displaying any of the above symptoms, he or she
should immediately see their primary health care provider.12
A number of factors should be examined in order to give an
accurate diagnosis. Factors such as the patient's travel history, symptoms and test results should be examined to determine if the patient is infected with Zika. 1 4 Available diagnostic tests include a blood (serum) test and a urine test, which
are used to confirm the presence of the Zika virus in an individuaJ.12 Reverse transcription polymerase chain reaction
(RT-PCR) tests are utilized to determine if a urine specimen
is positive for Zika virus. Viral RNA in urine has been found
to be positive as early as the first day of the onset of symptoms and as late as 20 days after onset of symptoms.is Serum
samples may also be obtained to screen for viral RNA using
polymerase chain reaction (PCR). If utilizing serum samples
for diagnostic purposes, results are more accurate if obtained
within seven days of symptom onset. Serum samples obtained more than one week after symptom onset may not
yield as accurate diagnostic results as urine samples. Therefore, urine samples should be used for patients who present
more than one week following onset of symptoms.12 Patients
who present as asymptomatic or are unable to give a serum
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or urine sample can undergo serology testing to confirm the
presence of Zika. This test looks for the body's reaction
against the virus in the form of antibodies that are present
within a week of being exposed to the virus. Antibodies also
remain in the patient's immune system months after infection. This serology testing is time-consuming and may not be
specific to the Zika virus. Other viruses with similar structures, such as the yellow fever virus, may cross-react and
result in a positive test. .
A positive result may, in fact, represent a previous exposure
to another virus or past vaccination, and therefore results
are difficult to interpret.16 Although anyone is susceptible to
Zika, testing should be reserved for individuals who have
traveled to high-risk areas in which the Zika virus is known
to be present. Special attention should be given to women
who become pregnant within two months of returning from
a high-risk area, and they should be tested even if they were
originally asymptomatic. Likewise, all symptomatic patients
with onset of Zika-like symptoms abroad or within 14 days
of return should be offered both viral and serologic testing
as part of a workup. There are a number of ways to detect
Zika in a potentially infected or asymptomatic individuat.12 It
is advised to attempt to gather a serum sample if possible,
but urine testing is becoming more favorable, as Zika virus
has been found up to 20 days after onset of symptoms. Further investigations are needed to evaluate whether the live
virus is excreted in urine. Although larger studies are needed
for confirmation, current research strongly suggests that
urine is a suitable specimen to be used to detect Zika in
patients beyond 14 days after symptom onset.17 Urine specimens are also likely suitable for use in epidemiologic investigations of a larger scale such as testing returning travelers.

Response from CDC/U.S. Food and Drug Administration
(FDA)/National Institute of Allergy and Infectious Diseases (NIAID)
One of the main concerns to patients is the risk of severe
fetal brain defects, such as microcephaly, associated with
Zika virus infection.1s In response to this, the CDC has established the US Zika Pregnancy Registry to collect information
regarding the timing and risks associated with Zika virus
infection and transmission during pregnancy. Patients who
are eligible to be enrolled in the registry include pregnant
women and their infants who have laboratory evidence of
Zika virus infection, with or without symptomatology. This
information will be used to update clinical recommendations
for the treatment and prevention of Zika virus during pregnancy.
Several health organizations are currently developing vaccines to target the Zika virus.19 One of these organizations,
the National Institute of Allergy and Infectious Diseases
(NIAID), is currently investigating several potential vaccine
candidates. In a phase I clinical trial, a live-attenuated Zika
vaccine based on the Dengue virus vaccine was shown to be
safe and induce an immunologic response. This Dengue
virus-based vaccine candidate is currently undergoing a
large phase III study in Brazil. Dengue virus and Zika virus
are both members of the flavivirus genus, and this similarity

4

was the rationale behind investigating this particular vaccine. West Nile virus is also a member of the flavivirus genus,. Consequently, a deoxyribonucleic acid (DNA)-based
vaccine for the Zika virus similar to the investigational vaccine for West Nile virus is also under investigation. This vaccine candidate is currently in an early stage trial. Another
vaccine candidate includes a genetically engineered vesicular stomatitis virus (VSV). The VSV recombinant vaccine
expresses the Zika virus E glycoprotein,20 and is therefore
being evaluated for potential use in preventing Zika virus in
tissue and animal models.19 Additionally, a whole-particle
inactivated Zika vaccine based on Japanese encephalitis and
Dengue virus vaccines is also being investigated. These vaccines are still in early developmental stages and are not expected to be available for several years.

Current Management and Changes
As the vaccines that are currently in development are still
several years from FDA approval, current management of
Zika consists of symptomatic treatment.21 This includes fluid
replacement for dehydration, rest and acetaminophen for
fever and pain. Due to the presence of similar symptomatology between Zika virus and dengue fever, aspirin and other
nonsteroidal anti-inflammatory drugs (NSAlDs) should be
avoided until dengue can be ruled out. Administration of
NSA!Ds to a patient with dengue fever significantly increases
hemorrhaging. Differential diagnosis can be performed via a
PCR test.
Because there are no current antiviral medications or vaccines available to treat Zika virus, preventing transmission is
an important counseling point.22 The most effective way to
prevent the transmission of Zika virus is to avoid traveling to
areas where Zika is present, when possible. If this is not possible, or the patient lives in an area where Zika is prevalent,
he or she should exercise extreme caution to prevent mosquito bites. This includes wearing long-sleeved shirts and
long pants that are treated with permethrin, staying in places with window and door screens, sleeping under a mosquito bed net and using United States Environmental Protection
Agency (EPA)-registered insect repellents. When using insect repellents and sunscreen, it is important to apply the
sunscreen before the insect repellent. Eliminating standing
water is vital to prevent further reproduction of the Aedes
species mosquitos responsible for the transmission of the
Zika virus. Sexual transmission of Zika virus can be prevented by using condoms or abstaining from sex. At this time, the
CDC is recommending that men who are exposed to Zika
virus use condoms or abstain from sex for at least six months
after returning from an area where Zika virus is present.23
Women who are exposed to Zika virus should use these
methods for at least eight weeks. Couples should be educated to use a reliable form of contraception to prevent the
transmission of Zika virus from mother to fetus.22

Conclusion
As more information is discovered about the Zika virus, it is
important for the public to remain informed about the virus
demographics and possible treatments and vaccines.
Understanding the virus's transmission, particularly through
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mosquito bites, sexual activity and from mother to fetus, is
imperative for taking proper preventive measures. As a
vaccine for the Zika virus is still several years away from
availability, these precautions become even more important.
Individuals who have traveled to Zika-infested areas or have
a reason to suspect they may have been infected with the
Zika virus should know the signs and symptoms of Zika and
should understand when or if they should be tested for the
virus. It is important for health care professionals to keep up
to date as data emerges and recommendations change, so
they can use this information to educate patients and address concerns about the Zika virus.
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Assessment Questions

1.

The first reports of locally transmitted Zika virus in the
United States came from _ _ _
A. Houston, Texas
B. Miami, Florida
C. New Orleans, Louisiana
D. San Diego, California

2.

After what major event did reports of Zika virus begin to
surface in Brazil?
A. 2014 FIFA World Cup
B. Carnival in 2015
C. 2016 Summer Olympics

3.

Which of the following has not been identified as a pathway of transmission of the Zika virus?
A. Sexual intercourse
B. Respiratory droplets
C. Mother to fetus
D. Bite from a mosquito

4.

What are the CDC's recommendations on breastfeeding
in areas where the Zika virus is prevalent?
A. Zika has not been identified in breast milk, so
breastfeeding is recommended.
B. Zika has not been identified in breast milk, but
breastfeeding should be avoided as a precaution.
C. Zika has been identified in breast milk, so
breastfeeding should be avoided.
D. Zika has been identified in breast milk, but
breastfeeding is recommended as the benefits
outweigh the risks.

5.

6.

A patient presents to your clinic suspecting they have
symptoms of Zika. Upon questioning, you find they had
travelled to Brazil and returned about a month ago, but
have only had symptoms on and off for the past 17 days.
Which of the following specimens could you test to
determine ifthe patient is infected with Zika?
1. Blood
2. Urine
3. Saliva
4. Semen
All of the following are potential symptoms for Zika except ~~~~~~~~~~~

A.
B.

C.
D.

6

Fever of 99.8° F
Headache
Constipation
Muscle pain

7. Which of the following is unlikely to put a patient at risk
for contracting Zika?
A. Traveling to Brazil or other areas known for
outbreaks of Zika.
B. Having a blood transfusion from a patient who
had recently been in a high risk area for Zika.
C. Not obtaining a proper medical workup after
travelling to a high risk area.
D. Travelling to areas known for outbreaks of the
yellow fever virus.
8.

Investigational vaccines for Zika virus often mimic
vaccines for which of the following infectious diseases
due to their similarities?
A. Human papilloma virus
B. Influenza
C. Herpes zoster
D. Dengue fever

9.

Appropriate treatment for Zika virus includes which of
the following?
A. acyclovir
B. acetaminophen
C. ibuprofen
D. Oseltamivir

10. At a minimum, how long should a couple wait before
trying to conceive a child if the man has recently traveled
to an area infected with Zika virus?
A. Eight weeks
B. Oneyear
C. Six months
D. If symptomatic, until symptoms resolve,
otherwise eight weeks.
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